The market is buzzing with gapping stocks on Monday. Let's uncover which stocks are experiencing notable gaps during today's session.
By Mill Chart
Last update: Apr 29, 2024
These stocks are gapping in today's session
Today's gap up stocks
| Ticker | Change | Comment |
|---|---|---|
| DCPH | 72.08% | DECIPHERA PHARMACEUTICALS IN's (NASDAQ:DCPH) shares rose 72.08% to $25.21 with a gap of 69.61% during Monday's session. The company is releasing earnings today. Earlier today the company had a press release: DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc. Is Fair to Shareholders. |
| CAUD | 70.85% | COLLECTIVE AUDIENCE INC's (NASDAQ:CAUD) stock price increased by 70.85% to $0.67 with a gap of 27.71%. Shareholders saw the stock price going 37.7% lower in the past month. |
| SLNO | 36.24% | In today's session, SOLENO THERAPEUTICS INC's (NASDAQ:SLNO) stock experienced a notable rise of 36.24%, reaching $51.62 with a significant 21.11% gap. The stock is trading 68.25% higher than 6 months ago. |
| PHG | 32.65% | KONINKLIJKE PHILIPS NVR- NY's (NYSE:PHG) shares soared 32.65% to $27.95 in Monday's session, displaying an impressive 31.39% gap. KONINKLIJKE PHILIPS NVR- NY released earnings Yesterday. |
| SINT | 32.43% | SINTX TECHNOLOGIES INC's (NASDAQ:SINT) shares surged 32.43% to $0.05 with a remarkable gap of 9.52%. The stock is trading 86.52% lower than 3 months ago. |
| IBRX | 24.9% | During Monday's session, IMMUNITYBIO INC's (NASDAQ:IBRX) stock price showed a remarkable increase of 24.9%, reaching $9.18 with a notable 7.62% gap. In the last month the stock gained 36.87%. |
| BTOG | 18.98% | During Monday's session, BIT ORIGIN LTD's (NASDAQ:BTOG) stock price showed a remarkable increase of 18.98%, reaching $3.95 with a notable 7.78% gap. The stock is trading 27.53% lower than 3 months ago. |
| PAHC | 17.36% | PHIBRO ANIMAL HEALTH CORP-A's (NASDAQ:PAHC) shares rose 17.36% to $14.94 with a gap of 6.0%. Yesterday the company had a press release: Zoetis to Sell Medicated Feed Additive Portfolio to Phibro Animal Health. |
| MULN | 16.95% | MULLEN AUTOMOTIVE INC's (NASDAQ:MULN) shares soared 16.95% to $3.7 during Monday's session, accompanied by a significant gap of 2.54%. A press release (California Issues HVIP Approval, Granting Mullen’s Class 3 EV Trucks a $45,000 Cash Voucher Per Vehicle Sold) was released earlier today. |
| HTLF | 16.78% | During Monday's session, HEARTLAND FINANCIAL USA INC's (NASDAQ:HTLF) stock price showed a remarkable increase of 16.78%, reaching $41.72 with a notable 11.45% gap. NASDAQ:HTLF is releasing earnings today. Earlier today the company had a press release: HTLF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Heartland Financial, USA Inc. Is Fair to Shareholders. |
For the full gap up stocks list go to our gap up stocks screener.
Today's top gap down stocks
| Ticker | Change | Comment |
|---|---|---|
| IONM | -27.66% | Today, ASSURE HOLDINGS CORP's (NASDAQ:IONM) stock experienced a 27.66% fall to $0.5 with a 62.13% gap. In the last month the stock gained 42.07%. |
| ATXI | -23.06% | AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares fell 23.06% to $4.77 during Monday's session with a gap of 47.05%. Earlier today the company had a press release: Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds. |
| CJJD | -19.43% | CHINA JO-JO DRUGSTORES HOLDI's (NASDAQ:CJJD) shares experienced a 19.43% decline to $2.28 during Monday's session, accompanied by a 32.99% gap. Shareholders saw the stock price going 22.44% lower in the past 3 months. |
| RWODR | -17.5% | In today's session, REDWOODS ACQUISITION-RIGHTS's (NASDAQ:RWODR) stock witnessed a 17.5% fall to $0.23 with a 20.32% gap. Shareholders saw the stock price going 75.0% higher in the past 3 months. |
| ANVS | -16.71% | Today, ANNOVIS BIO's (NYSE:ANVS) stock experienced a 16.71% fall to $15.0 with a 19.67% gap. Earlier today the company had a press release: Annovis Bio Announces Statistically Significant Phase II/III Data in Patients With Early Alzheimer’s Disease. |
| FFIE | -16.38% | FARADAY FUTURE INTELLIGENT E's (NASDAQ:FFIE) shares fell 16.38% to $0.04 with a gap of 26.92%. In the last month the stock lost 53.0%. |
| AQST | -14.25% | AQUESTIVE THERAPEUTICS INC's (NASDAQ:AQST) shares recorded a 14.25% decline to $3.49, with a notable 23.52% gap during today's session. Earlier today the company had a press release: Aquestive Therapeutics Receives U.S. FDA Approval and Market Access for Libervant™ (diazepam) Buccal Film in Pediatric Patients Ages 2 to 5 and Provides Update on Anaphylm™ (epinephrine) Sublingual Film. |
| ISUN | -13.33% | ISUN INC's (NASDAQ:ISUN) shares fell 13.33% to $0.15 with a gap of 23.68%. Shareholders saw the stock price going 32.8% lower in the past month. |
| SLS | -13.05% | Unfavorable news for SELLAS LIFE SCIENCES GROUP I's (NASDAQ:SLS) stock! It witnessed a 13.05% decline to $1.27 in today's session, along with a 22.33% gap. In the last month the stock gained 44.55%. |
| VIVK | -12.59% | In today's session, VIVAKOR INC's (NASDAQ:VIVK) stock price decreased by 12.59% to $1.18, exhibiting a 26.39% gap. Shareholders saw the stock price going 70.84% higher in the past month. |
Our gap down stocks screener will show you the full list.
SOLENO THERAPEUTICS INC
NASDAQ:SLNO (5/17/2024, 7:26:40 PM)
After market: 46.16 0 (0%)46.16
+0.5 (+1.1%)
SLNO News
This Prader-Willi Syndrome Awareness Day, May 15, join Soleno Therapeutics in sharing messages of hope and kindness for the Prader-Willi syndrome...
10 days ago - InvestorPlaceSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024SLNO stock results show that Soleno Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
10 days ago - BusinessInsiderSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soleno Therapeutics (NASDAQ:SLNO) just reported results for the first quarter o...
REDWOOD CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...
14 days ago - Market News VideoInvestors Snatch SLNO Even Lower Than Its Secondary Stock OfferingREDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage...
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), (
Statistically Significant Improvements with DCCR Compared to Natural History of PWS from the PATH for PWS Study in Hyperphagia and PWS-related Behaviors...
21 days ago - Market News VideoMonday Sector Leaders: Television & Radio, Drugs
21 days ago - The Motley FoolWhy Soleno Therapeutics Stock Is Skyrocketing TodayThe clinical-stage biotech company received great news from the FDA.
First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned...
REDWOOD CITY, Calif., April 19, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...
